Bridge City Capital LLC Invests $2.24 Million in National HealthCare Corporation $NHC

Bridge City Capital LLC purchased a new position in National HealthCare Corporation (NYSEAMERICAN:NHCFree Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 16,321 shares of the company’s stock, valued at approximately $2,237,000. Bridge City Capital LLC owned about 0.11% of National HealthCare as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also recently added to or reduced their stakes in the business. ProShare Advisors LLC grew its position in National HealthCare by 3.3% in the fourth quarter. ProShare Advisors LLC now owns 2,466 shares of the company’s stock worth $338,000 after buying an additional 78 shares during the last quarter. State of Alaska Department of Revenue grew its position in National HealthCare by 2.2% in the fourth quarter. State of Alaska Department of Revenue now owns 7,161 shares of the company’s stock worth $981,000 after buying an additional 152 shares during the last quarter. Quarry LP grew its position in National HealthCare by 171.9% in the third quarter. Quarry LP now owns 261 shares of the company’s stock worth $32,000 after buying an additional 165 shares during the last quarter. Simplex Trading LLC grew its position in National HealthCare by 140.0% in the fourth quarter. Simplex Trading LLC now owns 348 shares of the company’s stock worth $48,000 after buying an additional 203 shares during the last quarter. Finally, Caitong International Asset Management Co. Ltd acquired a new position in National HealthCare in the third quarter worth approximately $25,000. Institutional investors and hedge funds own 56.44% of the company’s stock.

Insider Buying and Selling

In other news, Director Lisa Piercey acquired 949 shares of the firm’s stock in a transaction that occurred on Monday, June 1st. The stock was purchased at an average price of $184.26 per share, with a total value of $174,862.74. Following the purchase, the director owned 949 shares of the company’s stock, valued at approximately $174,862.74. This trade represents a ∞ increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at the SEC website. Corporate insiders own 13.92% of the company’s stock.

National HealthCare Stock Performance

National HealthCare stock opened at $197.72 on Friday. The company has a 50 day moving average price of $180.59 and a 200 day moving average price of $159.79. National HealthCare Corporation has a 52 week low of $93.54 and a 52 week high of $205.06. The firm has a market capitalization of $3.09 billion, a price-to-earnings ratio of 25.12 and a beta of 0.64.

National HealthCare (NYSEAMERICAN:NHCGet Free Report) last posted its quarterly earnings data on Thursday, May 7th. The company reported $1.91 EPS for the quarter. National HealthCare had a net margin of 8.10% and a return on equity of 9.98%. The firm had revenue of $381.82 million during the quarter.

National HealthCare Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Tuesday, June 30th will be paid a $0.67 dividend. The ex-dividend date of this dividend is Tuesday, June 30th. This represents a $2.68 dividend on an annualized basis and a yield of 1.4%. This is a positive change from National HealthCare’s previous quarterly dividend of $0.64. National HealthCare’s dividend payout ratio (DPR) is 59.12%.

Wall Street Analysts Forecast Growth

Several research analysts have issued reports on NHC shares. BMO Capital Markets upgraded shares of National HealthCare to a “hold” rating in a research report on Monday, May 18th. Robert W. Baird upgraded shares of National HealthCare to a “strong-buy” rating in a research report on Monday, May 18th. The Goldman Sachs Group upgraded shares of National HealthCare to a “strong-buy” rating in a research report on Monday, May 18th. Finally, Royal Bank Of Canada upgraded shares of National HealthCare to a “hold” rating in a research report on Monday, May 18th. Two research analysts have rated the stock with a Strong Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat, National HealthCare presently has a consensus rating of “Buy”.

Check Out Our Latest Research Report on National HealthCare

National HealthCare Profile

(Free Report)

National HealthCare Corporation (NYSE American: NHC) is a healthcare services company specializing in long-term care and post-acute rehabilitation. The company operates skilled nursing facilities, assisted living communities and outpatient therapy clinics. Through its subsidiary, National HealthCare Partners, NHC provides contract rehabilitation services, pharmacy management and clinical consulting to a broad network of senior living and healthcare providers.

Headquartered in Murfreesboro, Tennessee, National HealthCare Corporation has built a regional footprint across the southeastern and south-central United States.

Featured Articles

Want to see what other hedge funds are holding NHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for National HealthCare Corporation (NYSEAMERICAN:NHCFree Report).

Institutional Ownership by Quarter for National HealthCare (NYSEAMERICAN:NHC)

Receive News & Ratings for National HealthCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National HealthCare and related companies with MarketBeat.com's FREE daily email newsletter.